Pharmaceutical agents for the treatment of alzheimer's disease

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/40 (2006.01) A61K 31/404 (2006.01)

Patent

CA 2217513

This invention relates to the use of certain 3-substituted 2-oxindole-1- carboxamides and their pharmaceutically acceptable base salts for the treatment or prevention of Alzheimer's disease in mammals, including humans.

La présente invention a pour objet l'utilisation de certains 2-oxindole-1-carboxamides à substitution en position 3 et de leurs sels basiques pharmaceutiquement acceptables dans le traitement ou la prévention de la maladie d'Alzheimer chez les mammifères, y compris chez l'homme.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical agents for the treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical agents for the treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical agents for the treatment of alzheimer's disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1418769

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.